These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 1796636

  • 1. [Positive inotropic substances--therapeutic perspectives].
    Erdmann E, Böhm M.
    Z Kardiol; 1991; 80 Suppl 8():57-62. PubMed ID: 1796636
    [Abstract] [Full Text] [Related]

  • 2. [Positive inotropic substances. Possible use in heart failure in the aged].
    Michel D.
    Fortschr Med; 1991 Aug 30; 109(25):496-9. PubMed ID: 1937336
    [Abstract] [Full Text] [Related]

  • 3. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J, Kramer W, Dieterich HA.
    Herz; 1990 Jun 30; 15(3):190-201. PubMed ID: 2198220
    [Abstract] [Full Text] [Related]

  • 4. [Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors].
    Stefenelli T.
    Acta Med Austriaca; 1991 Jun 30; 18(4):81-5. PubMed ID: 1763582
    [Abstract] [Full Text] [Related]

  • 5. Present use of positive inotropic drugs in heart failure.
    Schlepper M, Thormann J, Kremer P, Mitrovic V, Kramer W.
    J Cardiovasc Pharmacol; 1989 Jun 30; 14 Suppl 1():S9-19. PubMed ID: 2480492
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P.
    Therapie; 1989 Jun 30; 44(6):437-45. PubMed ID: 2576155
    [Abstract] [Full Text] [Related]

  • 7. New positive inotropic substances--true inotropy or peripheral effects?
    Wilmshurst P.
    Z Kardiol; 1988 Jun 30; 77 Suppl 5():103-11. PubMed ID: 3066033
    [Abstract] [Full Text] [Related]

  • 8. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH, Keren G, Reis D, Sonnenblick EH.
    J Cardiovasc Pharmacol; 1986 Jun 30; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [Abstract] [Full Text] [Related]

  • 9. Can pharmacological therapy influence the mortality of chronic congestive heart failure?
    Widimský J.
    Cor Vasa; 1992 Jun 30; 34(1):15-30. PubMed ID: 1288941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Drug therapy of heart failure].
    Follath F.
    Ther Umsch; 1993 Jun 30; 50(6):425-33. PubMed ID: 8351674
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of heart failure: what--when--how?].
    Blömer H.
    Verh Dtsch Ges Inn Med; 1990 Jun 30; 96():157-67. PubMed ID: 2092435
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Positive inotropic agents. Generalities and classification].
    Vahanian A, Le Potier J, Sergent J, Michel PL, Acar J.
    Ann Med Interne (Paris); 1985 Jun 30; 136(3):242-6. PubMed ID: 2862822
    [Abstract] [Full Text] [Related]

  • 17. [Mechanism of the positive inotropic effect of phosphodiesterase inhibitors].
    Scholz H, Dieterich HA, Schmitz W.
    Z Kardiol; 1991 Jun 30; 80 Suppl 4():1-6. PubMed ID: 1656618
    [Abstract] [Full Text] [Related]

  • 18. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M.
    J Cardiovasc Pharmacol; 1995 Jun 30; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [Abstract] [Full Text] [Related]

  • 19. Inotropic drugs for treatment of the failing heart.
    Maskin CS, Le Jemtel TH, Sonnenblick EH.
    Cardiovasc Clin; 1984 Jun 30; 14(3):1-17. PubMed ID: 6327040
    [No Abstract] [Full Text] [Related]

  • 20. Review: therapeutic concepts of congestive heart failure.
    Haustein KO.
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul 30; 28(7):273-81. PubMed ID: 1974888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.